RemeGen Co., Ltd. ( REGMF) - Key Metrics
REGMF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $9.24 | $7.71 | $7.48 | $7.42 |
| 2026Q1 | $1.16 | $0.58 | $0.02 | -$0.06 |
| 2025Q4 | $2.76 | $2.27 | -$0.29 | -$0.34 |
| 2025Q3 | $1.10 | -$0.18 | $0.82 | $0.72 |
| 2025Q2 | $1.08 | -$0.37 | -$0.11 | -$0.27 |
REGMF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 2.64 |
| 2026Q1 | 0% | 32.56 |
| 2025Q4 | 0% | 7.55 |
| 2025Q3 | 0% | -50.03 |
| 2025Q2 | -9.14% | -24.49 |
REGMF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 9.08% | 0% |
| 2026Q1 | -0.07% | 0% |
| 2025Q4 | -0.49% | 0% |
| 2025Q3 | 2.00% | 0% |
| 2025Q2 | -0.74% | 0.09% |
REGMF
Price: $9.96
52 week price:
Earnings Per Share: 1.55 USD
P/E Ratio: 7.05
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 5.6 billion